14 OCTOBER 2010 NEW ZEALAND GAZETTE, No. 140

GE Custodians ("the mortgagee" under the mortgage) hereby gives notice that it has entered into possession of the mortgaged land described below with effect from 6 October 2010.

The description of the mortgaged land is 304 Beaumont Quarter, Freemans Bay, Auckland, being all of the land comprised and described in certificate of title 513391.

The address to which communications relating to the mortgaged land may be addressed is GE Custodians, c/o Gibson Sheat Lawyers, Level 3, 1 Margaret Street, Lower Hutt. Facsimile: (04) 569 0301. Enquiries to: Paula Campbell. Email: paula.campbell@gibsonsheat.com

Signed and dated at Lower Hutt this 6th day of October 2010.

gn7937

GIBSON SHEAT, on Behalf of GE Custodians.

Note: This notice is given by the solicitors for the mortgagee at the offices of Gibson Sheat Lawyers, Level 3, 1 Margaret Street, Lower Hutt. Documents may be:

(a) posted to the solicitor at Gibson Sheat Lawyers, Private Bag 31905, Lower Hutt 5040; or

(b) left for the solicitor at the document exchange for direction to Gibson Sheat Lawyers, DX RP42008; or

(c) transmitted to the solicitor by facsimile to Gibson Sheat Lawyers. Facsimile: (04) 569 1571.

Departmental Notices

Agriculture and Forestry

Agricultural Compounds and Veterinary Medicines Act 1997

Notice of Application to Register a Trade Name Product (Notice No. 230)

Maree Zinzley, Senior Manager (Approval Operations) of the Ministry of Agriculture and Forestry ("MAF") (New Zealand Food Safety), acting under delegated authority from the Director-General of MAF, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 ("the Act"), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Dalmazin

Reference: A010591

Active Ingredient and Concentration:
D-cloprostenol 0.075g/L

Formulation Type: Aqueous solution

General Use Claim: For synchronisation or induction of oestrus and induction of parturition in cattle, horses and pigs.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

(a) where submissions on this application are to be sent; and

(b) where requests for copies of the public information relating to the application can be sent; and

(c) where public information relating to the application can be viewed; and

(d) the director-general’s address for service:

ACVM Group, New Zealand Food Safety (Ministry of Agriculture and Forestry), Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.

The applicant’s address for service is:

Ethical Agents Limited, 54 Hobill Avenue, Wiri, Manukau 2104. Postal Address: PO Box 97110, Manukau City 2241.

Dated at Wellington this 11th day of October 2010.

MAREE ZINZLEY, Senior Manager (Approval Operations)
(acting under delegated authority), Ministry of Agriculture and Forestry (New Zealand Food Safety).

go7961

Notice of Application to Register a Trade Name Product (Notice No. 231)

Maree Zinzley, Senior Manager (Approval Operations) of the Ministry of Agriculture and Forestry ("MAF") (New Zealand Food Safety), acting under delegated authority from the Director-General of MAF, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 ("the Act"), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Koagulon Vitamin K1 Syrup

Reference: A010506

Active Ingredient and Concentration:
Phytomenadione 10mg/mL

Formulation Type: Aqueous liquid (solution)

General Use Claim: For use as an adjunct to the treatment of coagulopathies associated with coumarin, warfarin and indanedione poisoning in dogs and cats.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

(a) must state in full the reasons for making the submission; and

(b) may state any decision sought on that application; and

(c) must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.